Label: FOLIVANE-F- ferrous fumarate, iron, folic acid, ascorbic acid, and niacin capsule

  • NDC Code(s): 13811-538-90
  • Packager: Trigen Laboratories, LLC
  • Category: DIETARY SUPPLEMENT
  • DEA Schedule: None
  • Marketing Status: Dietary Supplement

Drug Label Information

Updated August 15, 2018

If you are a consumer or patient please visit this version.

  • SUPPLEMENT FACTS

    Rev072018B

    Folivane™-F is a professionally prescribed iron, folic acid, and vitamin supplement used to improve the nutritional status of patients with iron and/or folate deficiency anemia, including women in the prenatal and postnatal period. Do not administer to children under the age of 12.

    Close
  • CONTRAINDICATIONS

    Folivane™-F is contraindicated in patients with a known hypersensitivity to any of the ingredients, also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindicated, as folic acid may obscure its signs and symptoms.

    Close
  • WARNINGS

     WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
    Close
  • PRECAUTIONS

    General: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where B12 is deficient. Anemia requires appropriate investigation to determine its cause or causes. Periodic clinical and laboratory studies are considered essential. Blood tests including hemoglobin and hematocrit should be done to determine the adequacy of therapy. Folic acid should be used with care in the presence of peptic ulcer disease, regional enteritis, and ulcerative colitis. In doses above 0.1 mg daily, folic acid may obscure the diagnosis of pernicious anemia.

    USAGE IN PREGNANCY
    Before Folivane™-F is prescribed for megaloblastic anemia in pregnancy, appropriate diagnostic exclusion of Addisonian pernicious anemia (due to faulty or blocked absorption of vitamin B12, or extrinsic factor or either a genetic, immunological or surgical basis) should be carried out.

    Pediatric Use: Safety and effectiveness of this product have not been established in pediatric patients.

    Geriatric Use: Safety and effectiveness of this product have not been established in elderly patients.

    Close
  • ADVERSE REACTIONS

    Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid.

    Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation, heartburn, and vomiting) occur occasionally, but are usually mild and may subside with continuation of therapy. Reducing the dose and administering it with meals will minimize these effects in the sensitive patient. Iron may turn stools black. This is a harmless effect that is a result of unabsorbed iron. Although the absorption of iron is best when taken between meals, giving Folivane™-F after meals may diminish occasional G.I disturbances. Folivane™-F is best absorbed when taken at bedtime.

    Close
  • OVERDOSAGE

    Acute overdosage of iron may cause abdominal pain, nausea and vomiting and, in severe cases, cardiovascular collapse and death.  Other more chronic symptoms include pallor and cyanosis, melena, shock, drowsiness, and coma.  The estimated overdose of orally ingested iron is 300 mg/kg body weight.  Toxic effects are seen at 10-20 mg/kg elemental iron.  When overdoses are ingested by children, severe reactions, including fatalities, have resulted.  Folivane™-F should be stored beyond the reach of children to prevent against accidental iron poisoning.

    Close
  • DESCRIPTION

    Folivane™-F are maroon capsules imprinted "T538" in white.

    Close
  • DIRECTIONS FOR USE

    One (1) capsule daily, between meals, or as directed by a physician.  Do not exceed recommended dosage. 

    Close
  • HOW SUPPLIED

    Folivane™-F is supplied in bottle of 90 capsules.
    Product Code: 13811-538-90

    Close
  • STORAGE

    Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure.

    Close
  • HEALTH CLAIM

    KEEP OUT OF THE REACH OF CHILDREN.

     For use on the order of a healthcare practitioner.

    Call your doctor about side effects. To report side effects, call Trigen Laboratories at 1-888-9-TRIGEN (1-888-987-4436) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

    Customer Service: 1-888-987-4436     Rev. 07/2018B

    Manufactured for:

    Trigen Laboratories, LLC

    Bridgewater, NJ 08807

    TRIGEN LOGO

    Close
  • PRINCIPAL DISPLAY PANEL - 90 Capsule Bottle Label

    13811-538-90

    Folivane - F
    with Ascorbic Acid Precursors

    IRON / FOLIC ACID / VITAMIN
    SUPPLEMENT CAPSULES

    90 CAPSULES

    TRIGEN
    LABORATORIES

    REV07/2018B
    Close
  • INGREDIENTS AND APPEARANCE
    FOLIVANE-F 
    ferrous fumarate, iron, folic acid, ascorbic acid, and niacin capsule
    Product Information
    Product Type DIETARY SUPPLEMENT Item Code (Source) NHRIC:13811-538
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION 62.5 mg
    IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7) IRON 62.5 mg
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID 1 mg
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID 40 mg
    NIACIN (UNII: 2679MF687A) (NIACIN - UNII:2679MF687A) NIACIN 3 mg
    Inactive Ingredients
    Ingredient Name Strength
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NHRIC:13811-538-90 90 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    DIETARY SUPPLEMENT 01/01/2010
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving % Daily Value
    color
    imprint
    scoring 1
    shape
    size (solid drugs) 20 mm
    Labeler - Trigen Laboratories, LLC (830479668)
    Close